GPR139
GPR139 (G protein-coupled receptor 139) is a protein that in humans is encoded by the GPR139 gene. GPR139 is an orphan G-protein–coupled receptor expressed in the central nervous system.
The expression pattern of GPR139 has primarily been studied on the mRNA level and showed expression mainly in the central nervous system.
GPR139 is an orphan receptor identified from bioinformatics analysis of the human genome. GPR139 is thus a potential target for the treatment of Parkinson’s disease, obesity, eating disorders, and/or diabetes.
The GPR139 is expressed specifically in the brain in areas of relevance for motor control. GPR139 function and signal transduction pathways are elusive, and results in the literature are even contradictory. GPR139 agonists dose-dependently protect primary dopaminergic (DA) neurons against MPP+ toxicity.
Targets for GPR139
Products for GPR139
- Cat.No. Nombre del producto Información
-
GC71095
GPR139 agonist-2
GPR139 agonist-2 (compuesto 20a) es un potente agonista de GPR139 con una EC50 de 24,7 nM.
-
GC19209
JNJ-63533054
JNJ-63533054 es un agonista potente y selectivo de hGPR139 con un EC50 = 16nM
-
GC69400
LP-471756
LP-471756 es un antagonista efectivo de GPR139, con un valor IC50 de 640 nM. LP-471756 inhibe la producción de cAMP estimulada por LP-360924.
-
GC66431
NCRW0005-F05
NCRW0005-F05 es un potente agonista de GPR139 con un valor IC50 de 0,21 μM. NCRW0005-F05 se puede utilizar para investigar la diabetes, la obesidad y la enfermedad de Parkinson'.